null
BETHPAGE VISUAL PERFORMANCE PILOT STUDY WITH EYEPROMISE®   VIZUAL EDGE PRO™

BETHPAGE VISUAL PERFORMANCE PILOT STUDY WITH EYEPROMISE® VIZUAL EDGE PRO™

Posted by EyePromise on Feb 16th 2022

Dr. Jeff Poplarski, Bethpage Golf Performance Director, and Kelley Brooke, President and Founder of Bethpage Golf Group, in conjunction with EyePromise® will be conducting a Visual Performance Pilot Study.

Details

  • WHEN: Thursday, February 24, 2022, 9am-5pm
  • WHERE: Bethpage Pro Shop, 99 Quacker Meeting House Road, Old Bethpage, N.Y. 11735
  • CONTACT PERSON: Dr. Jeff Poplarski, 516,456-1564 or via email: drjpop@gmail.com
  • COST TO PARTICIPATE IN STUDY: Free

Study Description

The purpose of this pilot study is to evaluate the efficacy of  EyePromise® Vizual Edge Pro™ through subjective and objective feedback in sports performance. Specifically, the impact of EyePromise® Vizual Edge Pro™ ocular nutrition supplement intervention on Macular Pigment Optical Density (MPOD) and contrast sensitivity in golfers over a 6-month time frame.

WHAT IS EYEPROMISE® VIZUAL EDGE PRO™?

EyePromise® Vizual Edge Pro™ is an NSF Certified for Sport eye health supplement designed to increase MPOD for improved visual performance.

What is Macular Pigment?

Macular pigment is a yellow pigment comprised of zeaxanthin and lutein, which accumulates in the eye’s central retina (macula) to protect and enhance vision. Often compared to your ‘internal sunglasses’, increasing the density of macular pigment is associated with the following:

Study Protocol

Evaluation will include the following components:

  • Macular Pigment Optical Density (MPOD) pre- and post-supplement intervention measurement using the QuantifEye® MPS II, which has noninvasively and accurately measured over 4 million eyes since 2006.
  • Ocular Nutritional Supplement Intervention: Each participant will be asked to consume the contents of one Vizual Edge Pro™ performance packet daily with food.
  • Pre- and post-supplement intervention questionnaires: Each participant will be asked to complete pre, during and post supplement questionnaires.
    • The pre- and post-pilot study evaluations will take each participant approximately 15 minutes. Baseline will be done on Thursday, February 24th, 2022, at Bethpage with the follow-up test done 6 months later, August 24th, 2022.

Protocol Design

  • Evaluation Type: Vizual Edge Pro™ nutritional supplement intervention
  • Actual Enrollment: 25 golfers
  • Time Perspective: 6 months
  • Official Title: BETHPAGE VISUAL PERFORMANCE PILOTSTUDY WITH EYEPROMISE® VIZUAL EDGE PRO™
  • Study Start Date: February 24th, 2022
    • Actual primary completion date: August 24th, 2022
    • Actual study completion date: September 2022

We're Looking for Participants!

Researchers are looking for male and female golfers ages 18 and up. The ideal candidate can consistently take a vitamin supplement over a 6-month period, is looking to improve golf performance, and has recently experienced one or more of the following:

  • Sensitivity to light
  • Difficulty driving at night
  • Difficulty reading the subtle contours of greens on a golf course

They are not looking for participants currently taking a supplement containing zeaxanthin, lutein, or Omega-3 fish oil.

If you're in the New York area and wish to participate, apply online here, or learn more about EyePromise Vizual Edge Pro.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.